DarioHealth Corp. (DRIO) |
| 7.6 -0.05 (-0.65%) 06-04 16:00 |
| Open: | 7.13 |
| High: | 7.69 |
| Low: | 6.97 |
| Volume: | 10,730 |
| Market Cap: | 56(M) |
| PE Ratio: | -0.89 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Medical - Diagnostics & Research |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 8.81 |
| Resistance 1: | 8.11 |
| Pivot price: | 7.85 |
| Support 1: | 6.97 |
| Support 2: | 5.80 |
| 52w High: | 17.744 |
| 52w Low: | 5.935 |
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
| EPS | -8.500 |
| Book Value | 9.840 |
| PEG Ratio | 0.00 |
| Gross Profit | 1.962 |
| Profit Margin (%) | -186.57 |
| Operating Margin (%) | -163.68 |
| Return on Assets (ttm) | -20.0 |
| Return on Equity (ttm) | -59.6 |
Tue, 26 May 2026
Dario More Than Doubles Addressable Market in Solera Health's Network via Expanded Hypertension Program, With Dario Now Reaching Greater Than 500,000 Eligible Lives - Sahm
Tue, 26 May 2026
Hypertension digital program deal lets DarioHealth reach 500,000 people - Stock Titan
Thu, 14 May 2026
DarioHealth Corp. (NASDAQ:DRIO) Q1 2026 Earnings Call Transcript - Insider Monkey
Wed, 13 May 2026
DarioHealth Reports First Quarter 2026 Financial and Operating Results - PR Newswire
Wed, 13 May 2026
DarioHealth Releases Q1 2026 Financial Results - AlphaStreet
Wed, 13 May 2026
DarioHealth Corp. (DRIO) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |